ECC Evansville Cancer Center
Home
Services
Physicians
Equipment
Activities
Headlines
Publications
Resources
Billing
Directions
Contact Us

ECC Welcomes New Radiation Oncologist to Expert Team
Dr. Subashini Yogeswaren Joins the Evansville Cancer Center’s Radiation Therapy Department

EVANSVILLE, Ind. – Evansville Cancer Center – Vantage Oncology has announced that Subashini Yogeswaren, M.D. has joined its team of radiology oncology experts at its state-of-the-art cancer center serving the Tri-State community. Dr. Yogeswaren, board certified in Therapeutic Radiology by the American Board of Radiology, specializes in the treatment of gynecological and neurological cancers and is experienced in stereotactic radiosurgery, high dose rate (HDR) and low dose rate (LDR) brachtherapy, 3-D treatment planning, intensity modulated radiation therapy (IMRT) and image-guided radiotherapy (IGRT).

Prior to her arrival, Dr. Yogeswaren served as a radiation oncologist at Sharp Memorial Hospital in San Diego, CA and is an active member in major national organizations including the American College of Radiation Oncology, American College of Radiology, American Brachytherapy Society, American Medical Association and American Association of Women Radiologists.

“It’s a tremendous opportunity for me to join the Evansville Cancer Center,” said Dr. Yogeswaren. “I look forward to collaborating with the cancer center’s dedicated team of medical and radiation oncologists to improve the quality of life for our patients. By having access to today’s most advanced radiation technologies, I believe we can make a tremendous difference in the fight against cancer.”

Dr. Yogeswaren received her medical degree and completed her internship and residency from Baylor College of Medicine in Houston, TX.

“We are excited to welcome Dr. Yogeswaren to our talented and experienced Radiation Therapy Department,” said Dr. Jon D. Frazier, Medical Director and radiation oncologist of Evansville Cancer Center. “Dr. Yogeswaren’s experience and dedication in the field of radiation oncology will have an immediate impact on the Cancer Center and our served communities.”

About Therapy Associates, PC
Therapy Associates was founded by Al Korba, M.D. and Ali J. Razek, M.D. in June 1983 to deliver radiation and medical oncology services. Today, Evansville-based Therapy Associates has nine board-certified medical and radiation oncologists and a board-eligible medial oncologist. The practice provides advanced medical and radiation therapy services to communities at six freestanding cancer centers in Indiana, Kentucky and Ohio. Therapy Associates has distinguished itself during the past 20 years as one of the premier radiation oncology groups in the nation with a proven record of excellence in clinical treatment, superiority in service delivery and technical acumen to develop new cancer treatment programs. For more information about Therapy Associates, visit
www.evansvillecancercenter.com.

About Evansville Cancer Center
Vantage Oncology’s Evansville Cancer Center currently offers pain and palliative services, diagnostic imaging, an on-site lab, cancer registry and a full-time psychologist. In addition, it offers High Dose Rate (HDR) Brachytherapy, an internationally recognized Gamma Med program and Intensity Modulated Radiation Therapy (IMRT). These advanced clinical treatment options permit precise targeting of radiation to a tumor, sparing critical normal organs, providing for better outcomes and fewer side effects for patients.

About Vantage Oncology, Inc.
Vantage Oncology, Inc. develops, acquires and operates state-of-the-art radiation oncology centers. El Segundo, Calif.-based Vantage Oncology is led by a seasoned management team, including Chief Executive Officer Michael Fiore, Chief Medical Officer Leslie Botnick, M.D., Chief Financial Officer Marshal Salomon and Chief Development Officer Mark Ahern. Vantage Oncology was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies and was funded by CCP Equity Partners, New Enterprise Associates, Versant Ventures and Salix Ventures. For more information about Vantage Oncology, visit
www.vantageoncology.com.




  Copyright © Evansville Cancer Center  •  All Rights Reserved  •  Disclaimer